Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 71-75

  Dublin, Edwin A ^a   Patel, Neera K ^a   Gillett, Cheryl E ^a   Smith, Paul ^a   Peters, Gordon ^b   Barnes, Diana M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTORS, ESTROGEN; RETINOBLASTOMA; SURVIVAL ANALYSIS;

EID: 0032548965     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K     Document Type: Article

References (21)

1. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int. J. Cancer, 61, 115-120 (1995).
2. WAF1 immuno-histochemical expression. Int. J. Cancer, 74, 171-174 (1997).
3. BARNES, D.M. and MILLIS, R.R., Oestrogen receptors: the history, the relevance and the methods of evaluation. In: N. Kirkham and N. Lemoine (eds.), Progress in pathology, Vol. 2, pp. 89-114, Churchill Livingstone, London (1995).
4. BERNS, E.M.J.J., DE KLEIN, A., VAN PUTTEN, W.L.J., VAN STAVEREN, I.L., BOOTSMA, A., KLIJN, J.G.M. and FOEKENS, J.A., Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. Int. J. Cancer, 64, 140-145 (1995).
5. ELSTON, C.W., The assessment of histological differentiation in breast cancer. Austr. N.Z. J. Surg., 54, 11-15 (1984).
6. FOSTER, J.S. and WIMALASENA, J., Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylatipn in breast cancer cells. Mol. Endocrinol., 10, 488-498 (1996).
7. GERADTS, J., HU, S.-X., LINCOLN, C.E., BENEDICT, W.F. and XU, H.-J., Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer, 58, 161-167 (1994).
8. 16INKFA in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res., 55, 6006-6011 (1995).
9. 16INK4A expression in human breast cancer. Amer. J. Pathol., 149, 15-20 (1996).
10. GILLETT, C., SMITH, P., GREGORY, W., RICHARDS, M., MILLIS, R., PETERS, G. arid BARNES, D., Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69, 92-99 (1996).
11. HALL, M. and PETERS, G., Genetic alterations of cyclins, cyclins-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108 (1996).
12. CDKN2 expression and its implications for cell immortalization and senescence. Mol. cell. Biol., 16, 859-867 (1996).
13. HUI, R., CORNISH, A.L., MCCLELLAND, RA, ROBERTSON, J.F.R., BLAMEY, R.W., MUSGROVE, E.A., NICHOLSON, R.I. and SUTHERLAND, R.L., Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin. Cancer Res., 2, 923-928 (1996).
14. INK4 expression in resected non-small cell lung tumors. Cancer Res., 56, 3415-3420 (1996).
15. LEE, E.Y.-H.P., TO, H., SHEW, J.-Y., BOOKSTEIN, R., SCULLY, P. and LEE, W.-H., Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science, 241, 218-220 (1988).
16. PIETILÄINEN, T., LIPPONEN, P., AALTOMAA, S., ESKELINEN, M., KOSMA, V.-M. and SYRJÄNEN, K., Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Europ. J. Cancer, 31A, 329-333 (1995).
17. REED, J.A., LOGANZO, JR., F., SHEA, C.R., WALKER, G.J., FLORES, J.F., GLENDENING, J.M., BOGDANY, J.K., SHIEL, M.J., HALUSKA, F.G., FOUNTAIN, J.W. and ALBINO, A.P., Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55, 2713-2718 (1995).
18. SAWAN, A., RANDALL, B., ANGUS, B., WRIGHT, C., HENRY, J.A., OSTROWSKI, J., HENNESSY, C., LENNARD, T.W.J., CORBETT, I. and HORNE, C.H.W., Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J. Pathol., 168, 23-28 (1992).
19. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res., 55, 6200-3209 (1995).
20. TRUDEL, M., MULLIGAN, L., CAVENEE, W., MARGOLESE, R., CÔTÉ, J. and GARIÉPY, G., Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum. Pathol., 23, 1388-1394 (1992).
21. WETNBEKO, R.A:, trie retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).